HLA-A∗02-gated safety switch for cancer therapy has exquisite specificity for its allelic target antigen

Innovative cell-based therapies are important new weapons in the fight against difficult-to-treat cancers. One promising strategy involves cell therapies equipped with multiple receptors to integrate signals from more than one antigen. We developed a specific embodiment of this approach called Tmod,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mock, Jee-Young, Winters, Aaron, Riley, Timothy P., Bruno, Richele, Naradikian, Martin S., Sharma, Shruti, Jette, Claudia A., Elshimali, Ryan, Gahrs, Casey, Toledo-Warshaviak, Dora, West, Anthony P., Kamb, Alexander, Hamburger, Agnes E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619369/
https://www.ncbi.nlm.nih.gov/pubmed/36381658
http://dx.doi.org/10.1016/j.omto.2022.09.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619369/
https://www.ncbi.nlm.nih.gov/pubmed/36381658
http://dx.doi.org/10.1016/j.omto.2022.09.010

Ejemplares similares